Edwards Lifesciences Corporation (EW) Q4 2011 Earnings Results

Edwards Lifesciences Beats on EPS, Stock Down 1.25%

Edwards Lifesciences reported a positive surprise in EPS, which indicates better-than-expected profitability. However, the stock fell by 1.25%, likely due to the lack of revenue details and forward guidance. Investors may be cautious given the absence of specific future projections.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.62	N/A	+4.91%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed confidence in their product pipeline while acknowledging market challenges. They are focused on innovation and efficiency.

Management highlighted strong performance in their core product lines.

They noted ongoing investments in R&D to drive future growth.

There was an emphasis on maintaining operational efficiency.

Edwards Lifesciences Beats on EPS, Stock Down 1.25%

Key numbers

Management commentary

Edwards Lifesciences Corporation

More earnings this week

Edwards Lifesciences Beats on EPS, Stock Down 1.25%

Key numbers

Management commentary